X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4679) 4679
Publication (822) 822
Book Review (44) 44
Book Chapter (32) 32
Dissertation (14) 14
Conference Proceeding (10) 10
Government Document (3) 3
Magazine Article (2) 2
Book / eBook (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2777) 2777
indoleamine 2,3-dioxygenase (2751) 2751
humans (2498) 2498
animals (2059) 2059
immunology (1412) 1412
dendritic cells (1168) 1168
tryptophan (1153) 1153
female (1144) 1144
indoleamine-pyrrole 2,3,-dioxygenase - metabolism (1086) 1086
mice (1085) 1085
male (1059) 1059
tryptophan catabolism (678) 678
inflammation (670) 670
expression (654) 654
interferon-gamma (654) 654
cancer (631) 631
tryptophan - metabolism (616) 616
regulatory t-cells (589) 589
t cells (546) 546
biochemistry & molecular biology (543) 543
immunotherapy (542) 542
indoleamine-pyrrole 2,3,-dioxygenase - genetics (540) 540
oncology (513) 513
neurosciences (511) 511
cell biology (488) 488
enzymes (482) 482
middle aged (472) 472
adult (471) 471
analysis (462) 462
ido (462) 462
cells, cultured (456) 456
article (449) 449
research (440) 440
tolerance (428) 428
inhibition (426) 426
dendritic cells - immunology (419) 419
physiological aspects (415) 415
mice, inbred c57bl (411) 411
kynurenine (404) 404
cytokines (391) 391
t-cells (379) 379
kynurenine - metabolism (376) 376
indoleamine 2 (374) 374
medicine, research & experimental (347) 347
metabolism (346) 346
health aspects (341) 341
3-dioxygenase (337) 337
t-lymphocytes, regulatory - immunology (337) 337
ifn-gamma (334) 334
metabolites (327) 327
indoleamine-pyrrole 2,3,-dioxygenase - antagonists & inhibitors (321) 321
quinolinic acid (315) 315
gene expression (313) 313
immunosuppression (306) 306
in-vivo (306) 306
lymphocytes (306) 306
pharmacology & pharmacy (297) 297
t-lymphocytes - immunology (296) 296
rats (290) 290
kynurenine pathway (289) 289
activation (288) 288
indoleamine-pyrrole 2,3,-dioxygenase - immunology (286) 286
aged (285) 285
tryptophan 2,3-dioxygenase (285) 285
immune tolerance (282) 282
induction (282) 282
immune system (275) 275
transplantation (274) 274
cell proliferation (263) 263
immune response (260) 260
hematology (252) 252
indoleamine-pyrrole 2,3,-dioxygenase (248) 248
tumors (248) 248
apoptosis (244) 244
care and treatment (242) 242
research article (240) 240
lymphocytes t (233) 233
disease models, animal (229) 229
interferon (228) 228
pregnancy (227) 227
serotonin (227) 227
cells (226) 226
mice, inbred balb c (224) 224
signal transduction (223) 223
brain (221) 221
immunohistochemistry (217) 217
tryptophan oxygenase - metabolism (212) 212
interferon-gamma - pharmacology (210) 210
mice, knockout (208) 208
depression (206) 206
multidisciplinary sciences (206) 206
cytokines - metabolism (204) 204
medicine (204) 204
stem cells (204) 204
cell line, tumor (203) 203
immunomodulation (203) 203
macrophages (203) 203
tryptophan - blood (203) 203
aryl-hydrocarbon receptor (197) 197
psychiatry (196) 196
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4656) 4656
Chinese (23) 23
Japanese (13) 13
Korean (8) 8
Portuguese (4) 4
Russian (3) 3
German (2) 2
Czech (1) 1
French (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic Oncology, ISSN 0090-8258, 09/2017, Volume 146, Issue 3, pp. 484 - 490
Indoleamine 2,3-dioxygenase-1 (IDO1) is a key regulator of immune tolerance in ovarian cancer. This study investigated efficacy and safety of the IDO1 enzyme... 
Epacadostat | IDO1 enzyme inhibitor | Tamoxifen | Ca-125 | Ovarian cancer | SURVIVAL | DIAGNOSIS | PROTEIN | PROGNOSIS | INDOLEAMINE 2,3-DIOXYGENASE | OBSTETRICS & GYNECOLOGY | ONCOLOGY | IMMUNOTHERAPY | EXPRESSION | T-CELLS | Recurrence | Neoplasms, Glandular and Epithelial - chemistry | Oximes - pharmacokinetics | Oximes - adverse effects | Peritoneal Neoplasms - blood | Humans | Middle Aged | Oximes - therapeutic use | Response Evaluation Criteria in Solid Tumors | Fatigue - chemically induced | Peritoneal Neoplasms - chemistry | Antineoplastic Agents, Hormonal - adverse effects | Early Termination of Clinical Trials | Fallopian Tube Neoplasms - blood | Neoplasms, Glandular and Epithelial - blood | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - chemistry | Exanthema - chemically induced | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Ovarian Neoplasms - drug therapy | Pruritus - chemically induced | Fallopian Tube Neoplasms - drug therapy | Drug Eruptions - etiology | Ovarian Neoplasms - chemistry | CA-125 Antigen - blood | Indoleamine-Pyrrole 2,3,-Dioxygenase - analysis | Ovarian Neoplasms - blood | Survival Rate | Sulfonamides - pharmacokinetics | Disease-Free Survival | Sulfonamides - therapeutic use | Tamoxifen - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Sulfonamides - adverse effects | Aged | Tamoxifen - adverse effects | Indoleamine-Pyrrole 2,3,-Dioxygenase - antagonists & inhibitors | Care and treatment | Chemotherapy | Enzyme inhibitors | Cancer | Medical research | Medicine, Experimental
Journal Article
Immunology, ISSN 0019-2805, 10/2015, Volume 146, Issue 2, pp. 292 - 300
Summary Indoleamine 2,3‐dioxygenase (IDO) is expressed in antigen‐presenting cells and exerts immunosuppressive effects on CD4+ T cells. One mechanism is... 
fatty acid | indoleamine 2,3‐dioxygenase | general control non‐derepressible 2 kinase | acetyl coenzyme A carboxylase 1 | T cells | ATP‐citrate lyase | Indoleamine 2,3-dioxygenase | Acetyl coenzyme A carboxylase 1 | Fatty acid | ATP-citrate lyase | General control non-derepressible 2 kinase | SURVIVAL | GCN2 | TOLERANCE | INDUCTION | IMMUNOLOGY | GLYCOLYSIS | AMINO-ACID | INHIBITION | METABOLISM | ARYL-HYDROCARBON RECEPTOR | general control non-derepressible 2 kinase | indoleamine 2,3-dioxygenase | EXPRESSION | Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism | Cell Proliferation | Signal Transduction | TOR Serine-Threonine Kinases - metabolism | Lymphocyte Activation | Down-Regulation | Humans | Cells, Cultured | CD4-Positive T-Lymphocytes - enzymology | Lymphocyte Culture Test, Mixed | Mechanistic Target of Rapamycin Complex 1 | CD4-Positive T-Lymphocytes - immunology | Gene Expression Regulation, Enzymologic | Multiprotein Complexes - metabolism | Tryptophan - deficiency | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Differentiation | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | CD4-Positive T-Lymphocytes - drug effects | Indoleamine-Pyrrole 2,3,-Dioxygenase - antagonists & inhibitors | Protein-Serine-Threonine Kinases - metabolism | Fatty Acids - biosynthesis | Enzymes | Cell growth | T cell receptors | Dehydrogenases | Kinases | Lymphocytes | Original
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2015, Volume 10, Issue 2, pp. e0118562 - e0118562
Dendritic cells (DC) interact with naive T cells to regulate the delicate balance between immunity and tolerance required to maintain immunological... 
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | IN-VITRO | NOD MICE | INHIBITION | ARYL-HYDROCARBON RECEPTOR | NONOBESE DIABETIC MICE | IMMUNE-RESPONSES | MULTIDISCIPLINARY SCIENCES | REGULATORY T-CELLS | 2,3-DIOXYGENASE | TRYPTOPHAN CATABOLISM | Indoleamine-Pyrrole 2,3,-Dioxygenase - biosynthesis | Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics | Signal Transduction | Monocytes - cytology | Vaccines, Subunit - genetics | Dendritic Cells - immunology | Humans | Monocytes - metabolism | NF-kappa B - metabolism | Proinsulin - genetics | Proteome | Gene Expression Profiling | Vaccines, Subunit - immunology | Cholera Toxin - genetics | Proteomics | Cholera Toxin - immunology | Cell Differentiation | Dendritic Cells - cytology | Dendritic Cells - metabolism | Cluster Analysis | Proinsulin - immunology | Autoimmunity | Enzymes | Dendritic cells | Type 1 diabetes | Vaccination | Physiological aspects | Tryptophan | Protein biosynthesis | Cholera | Vaccines | Cholera toxin | T cells | Disease | Mucosa | Bar codes | Hydrocarbons | Biochemistry | Immunity | Proteins | Hyperglycemia | Inhibition | Fusion protein | Public health | Cholera toxin B subunit | NF-κB protein | Dioxygenase | Antigens | Cytokines | Toxin b | Insulin | Immunological tolerance | Immunosuppression | Protein synthesis | Water-borne diseases | Homeostasis | Lymphocytes T | Diabetes mellitus (insulin dependent) | Infections | Biosynthesis | Kinases | Inoculation | Immunology | Lymphocytes | Pancreas | Immune system | Degradation products | Maturation | Therapeutic applications | Diabetes mellitus | Inflammation | Pharmacology | Medicine | Monocytes | Diabetes | Autoimmune diseases | Dendritic structure | Health disparities | Index Medicus
Journal Article
Scientific Reports, 12/2016, Volume 6, p. 38308
Journal Article
Microbiology and Immunology, ISSN 0385-5600, 02/2018, Volume 62, Issue 2, pp. 71 - 79
Journal Article